AI generated image of female cancer patient and tablet box.

Hormone Therapy for Cancer

Some cancers, like breast and prostate cancer, need hormones to grow and spread (1). If you have a cancer like this, your care team may consider placing you on hormone therapy. Hormone therapy may be used on its own, or used alongside surgery, chemotherapy, radiation therapy, or other targeted therapies (2). This article aims to help you understand what hormone therapy really is and how it may be useful during your cancer treatment. 

AI generated image of two females potting herbs.

What is Hormone Therapy?

Hormone therapy is an approach to cancer treatment that works by reducing the level of hormones in your blood that cancers require to grow. Hormone therapy is commonly used for cancers that show sensitivity to hormones. Different types of hormone therapies target different hormones, depending on the type of cancer you have. Hormone therapy can continue for months, years or lifelong depending on your treatment plan. 

Which Cancers can Hormone Therapy Treat?

Hormone therapy is most commonly used to treat prostate and breast cancer. But it can also be used for other hormone-sensitive cancers like endometrial cancer, ovarian cancer, and rarely for thyroid cancer, among others (3). You would usually have to be tested before hormone therapy is commenced to determine if your cancer is hormone-receptor positive. If your cancer is hormone-receptor positive, it means hormone therapy is likely to work for controlling it.

Types of Hormone Therapy

Hormone therapy typically falls into two broad groups: those that block the production of a hormone that drives a cancer completely, and those that change or influence how a hormone acts in the body (4).

Different hormone therapy approaches include:

  • Medicines that stop hormones from reaching the cancer cells. These drugs do not stop your glands from producing hormones, but they stop the hormones from reaching any cancer cells.
  • Medicines that block hormones from being produced in the body. These treatments reduce hormone production by the testes or ovaries, lowering the levels of hormones that may fuel cancer growth.
  • Medications that reduce the amount of hormones being produced.
  • Surgery to remove hormone-producing organs. Sometimes surgery is done to remove the testis, ovary, and other glands that produce hormones that drive cancer.

Hormone Therapy for Breast Cancer

Hormone therapy is used to treat hormone-receptor-positive breast cancers by reducing the effect of estrogen on cancer cells (5). Many hormone receptor-positive breast cancer cells rely on estrogen signalling to grow. Reducing estrogen activity can slow or stop the growth of these cancers. Some drugs used in hormone therapy for breast cancer include tamoxifen and aromatase inhibitors. Tamoxifen works differently from aromatase inhibitors and may be used in different patient groups depending on factors such as menopause and the stage of the cancer. 

Tamoxifen works by blocking estrogen receptors on breast cancer cells, preventing estrogen from stimulating their growth. Aromatase inhibitors work differently by reducing the body's production of estrogen, mainly in tissues outside the ovaries after menopause (6, 7).

Hormone therapy medication for breast cancer can be taken for several years as a part of a long-term treatment and as a way to prevent the cancer from returning.

Hormone Therapy for Prostate Cancer

Hormone therapy for prostate cancer aims at reducing the levels of testosterone across the body or the hormone’s effect on cancer cells, so that they stop growing (8). 

Androgen deprivation therapy (ADT) is a common hormone therapy approach for prostate cancer. 

It can be given as injections, implants, tablets, or by removing both testes, depending on the treatment plan (9). 

It can be used alone or alongside other treatment plans like chemotherapy and radiation therapy or a new type of anti-androgen regimen.  

DID YOU KNOW?

Did you know that hormone therapy can be used to treat various cancers, including cancer of the ovary, prostate and breast?

How is Hormone Therapy Given?

Hormone therapy may be given as tablets, capsules, or injections. Some treatments are taken daily (like tablets), while others are taken monthly or once every few months. Your treatment plan can vary between you and other people, depending on your cancer type and stage. 

Common Side Effects of Hormone Therapy

Hormone therapy has some side effects. Not everyone experiences these effects the same way. You may experience side effects while someone else does not or vice versa. Side effects of hormone therapy generally vary between people and their treatment types. The most common ones include:(10)

  • Hot flashes
  • Fatigue
  • Mood changes
  • Joint or muscle pain
  • Muscle mass loss and abdominal fat gain
  • Menopausal symptoms
  • Low libido
  • Bone thinning or osteoporosis.

Living with Hormone Therapy

Because hormone therapy is often taken for a long period, you may feel affected physically and emotionally by it (11). Your relationships may also be strained, and your daily routines may experience some changes. Consider receiving follow-up care and discuss any ongoing symptoms or concerns with your healthcare team. 

Supporting your Body during Hormone Therapy

Side effects of hormone therapy, such as fatigue, changes in your appetite, or digestive symptoms, can affect your well-being. You need to stay properly hydrated, get enough nutrition, and achieve just the right amount of physical activity, which improves bone health. This can support overall health during treatment. Some people may benefit from nutritional support like oral nutritional supplements; this is especially true if your treatment affects your appetite, energy levels, and food intake more than you can keep up with. 

Key Takeaways

Hormone therapy is used to treat cancers that depend on hormones to grow. It includes drugs and injections that can block the hormones from being produced, block the hormones from reaching cancer cells, or change how cancer cells interact with these hormones. It's taken for a very long time and, as such, has a toll on your physical, emotional, and mental well-being. You should speak to your doctor concerning any side effects, especially those that bother you. 

References:

  1. [1] Miki Y. Hormone-Dependent Cancers: New Aspects on Biochemistry and Molecular Pathology. Int J Mol Sci. 2023 Jun 29;24(13):10830. doi: 10.3390/ijms241310830. PMID: 37446008; PMCID: PMC10341538.
  2. [2] Bajaj K, et al. Combination chemotherapy and hormone therapy in patients with hormone receptor positive and HER2 negative metastatic breast cancer. Sci Rep. 2025 Aug 1;15(1):28172. doi: 10.1038/s41598-025-12419-3. PMID: 40750803; PMCID: PMC12316914.
  3. [3] Ahmed M, et al.  Considering hormone-sensitive cancers as a single disease in the UK biobank reveals shared aetiology. Commun Biol. 2022 Jun 21;5(1):614. doi: 10.1038/s42003-022-03554-y. PMID: 35729236; PMCID: PMC9213416.
  4. [4] Desai K, et al. Hormonal Therapy for Prostate Cancer. Endocr Rev. 2021 May 25;42(3):354-373. doi: 10.1210/endrev/bnab002. PMID: 33480983; PMCID: PMC8152444.
  5. [5] Nabieva N, and Fasching PA. Endocrine Treatment for Breast Cancer Patients Revisited-History, Standard of Care, and Possibilities of Improvement. Cancers (Basel). 2021 Nov 11;13(22):5643. doi: 10.3390/cancers13225643. PMID: 34830800; PMCID: PMC8616153.
  6. [6] Janni W, et al.  Systematic literature review and trial-level meta-analysis of aromatase inhibitors vs tamoxifen in patients with HR+/HER2- early breast cancer. Breast. 2025 Jun;81:104429. doi: 10.1016/j.breast.2025.104429. Epub 2025 Mar 5. PMID: 40153939; PMCID: PMC11992420.
  7. [7] Record H, et al. Tamoxifen or aromatase inhibitors with ovarian function suppression in pre-menopausal stage I-III lobular breast cancer. NPJ Breast Cancer. 2023 Oct 26;9(1):88. doi: 10.1038/s41523-023-00594-3. PMID: 37884561; PMCID: PMC10603127.
  8. [8] Zhao X, et al. The Role of Serum Testosterone in the Pathogenesis and Treatment of Prostate Cancer: A Review Based on the Clinical Evidence. Int J Urol. 2025 Sep;32(9):1102-1117. doi: 10.1111/iju.70125. Epub 2025 May 23. PMID: 40407001.
  9. [9] Reiss AB, et al. Androgen Deprivation Therapy for Prostate Cancer: Focus on Cognitive Function and Mood. Medicina (Kaunas). 2023 Dec 30;60(1):77. doi: 10.3390/medicina60010077. PMID: 38256338; PMCID: PMC10819522.
  10. [10] de Freitas Corpes E, et al. Side effects of hormone therapy in patients with malignant breast neoplasm: a cross-sectional study. Rev Bras Enferm. 2025 Dec 8;78(4):e20240536. doi: 10.1590/0034-7167-2024-0536. PMID: 41370618; PMCID: PMC12716806.
  11. [11] Chen J, et al. Optimal duration of endocrine therapy with extended aromatase inhibitors for postmenopausal patients with hormone receptor-positive breast cancer: a meta-analysis. Breast Cancer. 2021 May;28(3):630-643. doi: 10.1007/s12282-020-01196-8. Epub 2021 Jan 2. PMID: 33387283.

Disclaimer

This information is provided for educational purposes only. It is general in nature and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult your healthcare team regarding any questions or concerns about your health or care.

Related Pages